Streptococcus pneumoniae is responsible for two-thirds of ICU admissions due to
community-acquired pneumonia (CAP) and is the leading cause of CAP-related death. Early …

Objective To determine mortality and factors that might predict outcome in severe community-
acquired pneumococcal pneumonia treated by a standard protocol. Design Prospective …

Multiple severity scoring systems have been devised and evaluated in community-acquired
pneumonia (CAP), but a simplified set of prognostic indicators has not yet been developed …

Background Most guidelines have been proposing, for more than 15 years, a β-lactam
combined with either a quinolone or a macrolide as empirical, first-line therapy of severe …

Hospitalized patients with community-acquired pneumonia should have blood cultures
obtained to confirm the possibility of bacteremic pneumococcal pneumonia. Based on …

The large number of guidelines that have been published for the management of community-
acquired pneumonia (CAP) reflects that (i) it is a very common disease,(ii) it is relatively …

Despite all published literature, controversies remain about the optimal antibiotic treatment
in community-acquired pneumonia. The most debated issue is whether it is necessary to …

Community-acquired pneumonia (CAP) is a serious condition associated with significant
morbidity and potential long-term mortality. Although the majority of patients with CAP are …

The cost, morbidity and mortality of CAP patients requiring ICU admission remain
unacceptably high. These are heterogeneous groups of patients, so it is important to use risk …

Community-acquired pneumonia (CAP) is a common and serious problem in the United
States, and the sixth leading cause of death in those over age 65. Not only has short-term …